Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Clinical benefit of enzyme replacement therapy in Fabry disease. — Giuseppe Remuzzi | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Clinical benefit of enzyme replacement therapy in Fabry disease.
Shared by
Giuseppe Remuzzi
Faculty Opinions recommendation of Clinical benefit of enzyme replacement therapy in Fabry disease.
Dataset
en
Authors
Giuseppe Remuzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Enzyme Replacement Therapy and Fabry Nephropathy
David G. Warnock
,
Erica Daina
,
Giuseppe Remuzzi
,
Michael L. West
Dataset
Faculty Opinions recommendation of GnRH replacement rescues cognition in Down syndrome.
George Chrousos
,
George Paltoglou
Dataset
Faculty Opinions recommendation of Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
George Perry
Dataset
Faculty Opinions recommendation of Volume progression in polycystic kidney disease.
Giuseppe Remuzzi
Dataset
Faculty Opinions recommendation of Diagnostic considerations for cholestatic liver disease.
Ralf Weiskirchen
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.